Why the study?
Acute fulminant myocarditis has a rapid and deadly progression requiring aggressive treatment, but key management uncertainties including the timing of ECMO initiation and left ventricular decompression require further investigation.
Does extracorporeal membrane oxygenation improve outcomes in children with acute fulminant myocarditis?
Does extracorporeal membrane oxygenation improve outcomes in children with acute fulminant myocarditis?
ECMO should be considered early in children with acute fulminant myocarditis due to its unpredictable clinical course and potential for rapid hemodynamic collapse.
Answers are grounded in this paper and cite their sources.
May identify children needing ECMO support; hypothesis-generating for outcome trials.
Acute fulminant myocarditis (AFM) occurs as an inflammatory response to an initial myocardial insult. Its rapid and deadly progression calls for prompt diagnosis with aggressive treatment measures. The demonstration of its excellent recovery potential has led to increasing use of mechanical circulatory support, especially extracorporeal membrane oxygenation (ECMO). Arrhythmias, organ failure, elevated cardiac biomarkers, and decreased ventricular function at presentation predict requirement for ECMO. In these patients, ECMO should be considered earlier as the clinical course of AFM can be unpredictable and can lead to rapid haemodynamic collapse. Key uncertainties that clinicians face when managing children with AFM such as timing of initiation of ECMO and left ventricular decompression need further investigation.
No takes yet. Share an insight, caveat, or question.
Heinsar et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: